Journal of Clinical Investigation · 2013 · 82 citations · 43 references
Life SciencesGeneticsMolecular BiologyAutoimmunityGene ExpressionGene TherapyAntifibrotic TherapyHepatic FibrosisHepatic PathophysiologyLiver DiseaseAlpha-1 Antitrypsin DeficiencyAntisense RnasGenetic Liver DiseaseLiver Disease-related Protein ChangesLiver Fibrosis ProgressionProtein AggregatesTransgenic Mouse Modelsα1-Antitrypsin Deficiency
Alpha-1 antitrypsin deficiency (AATD) is a rare genetic disease that results from mutations in the alpha-1 antitrypsin (AAT) gene. The mutant AAT protein aggregates and accumulates in the liver leading to AATD liver disease, which is only treatable by liver transplant. The PiZ transgenic mouse strain expresses a human AAT (hAAT) transgene that contains the AATD-associated Glu342Lys mutation. PiZ mice exhibit many AATD symptoms, including AAT protein aggregates, increased hepatocyte death, and liver fibrosis. In the present study, we systemically treated PiZ mice with an antisense oligonucleotide targeted against hAAT (AAT-ASO) and found reductions in circulating levels of AAT and both soluble and aggregated AAT protein in the liver. Furthermore, AAT-ASO administration in these animals stopped liver disease progression after short-term treatment, reversed liver disease after long-term treatment, and prevented liver disease in young animals. Additionally, antisense oligonucleotide treatment markedly decreased liver fibrosis in this mouse model. Administration of AAT-ASO in nonhuman primates led to an approximately 80% reduction in levels of circulating normal AAT, demonstrating potential for this approach in higher species. Antisense oligonucleotides thus represent a promising therapy for AATD liver disease.
43
The mechanism of Z α1-antitrypsin accumulation in the liver
David A. Lomas, Dyfed LI-Evans, J.T. Finch et al. · Nature · 1992 · 1.1K citations
Frederick J. Raal, Raúl D. Santos, Dirk Blom et al. · The Lancet · 2010 · 906 citations
Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells
Kosuke Yusa, S. Tamir Rashid, Hélène Strick‐Marchand et al. · Nature · 2011 · 640 citations · Full text